Request for TOC Request for Sample
BUY NOW

Global Epinephrine Auto-Injector Market – Industry Trends and Forecast to 2029

Healthcare | Upcoming Report | Aug 2022 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60
Nucleus

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Epinephrine Auto Injector Market

Market Size in USD Billion

CAGR :  %

USD 1.88 Billion USD 3.56 Billion 2021 2029
Forecast Period
2022 –2029
Market Size(Base Year)
USD 1.88 Billion
Market Size (Forecast Year)
USD 3.56 Billion
CAGR
%
Major Markets Players
  • Adamis Pharmaceuticals Corporation ALK Antares Pharma Bausch + Lomb Incorporated HospiraInc. Impax LaboratoriesInc. Lincoln Medical Mylan N.V. Teva Pharmaceutical Industries Ltd. Impax Pfizer Inc. Amphastar PharmaceuticalsInc. Emerade Grand Pharma Group Limited Harvest Pharmaceuticals Merit Healthcare International Inc. Tianjin Jinyao Group

Global Epinephrine Auto-Injector Market, By Product Type (Type 0.30 mg, 0.15 mg), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End-User (Hospitals, Clinics, Individuals) – Industry Trends and Forecast to 2029.

Get Exclusive Sample Copy of this Report Here

Epinephrine Auto-Injector Market Analysis and Size

People with severe allergies utilize hand-held medical devices called epinephrine auto-injectors. Epinephrine injections are frequently used to treat allergies that can be fatal and are brought on by stings, bug bites, or medications. Adrenaline injections are administered using automated prefilled injectable devices that are prefilled with liquid epinephrine. A single-use, disposable, spring-loaded syringe is the most typical kind of auto-injector. Due to its design, it is easy to use and can be administered by unskilled staff members or patients.

Data Bridge Market Research analyses that the epinephrine auto-injector market which was USD 1.88 billion in 2021, would rocket up to USD 3.56 billion by 2029, and is expected to undergo a CAGR of 8.30% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Epinephrine Auto-Injector Market Scope and Segmentation    

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Type 0.30 mg, 0.15 mg), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End-User (Hospitals, Clinics, Individuals)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

  • Adamis Pharmaceuticals Corporation (U.S.), ALK (Denmark), Antares Pharma (U.S.), Bausch + Lomb Incorporated (U.K.), Hospira, Inc. (U.S.), Impax Laboratories, Inc. (U.S.), Lincoln Medical (U.S.), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Impax (U.S.), Pfizer Inc. (U.S.), Amphastar Pharmaceuticals, Inc. (U.S.), Emerade (U.S.), Grand Pharma Group Limited (Hong Kong), Harvest Pharmaceuticals (U.S.), Merit Healthcare International Inc. (U.S.), Tianjin Jinyao Group (China)

Market Opportunities

  • Increased awareness of allergies
  • Technological developments in research and development (R&D) activities

Market Definition

Epinephrine also known as adrenaline, is a hormone released from adrenal glands to treat allergic reactions. An auto-injector for epinephrine or adrenaline is a medical tool used to treat anaphylaxis. They are sold as pre-filled auto injecting devices that include the medication to be injected under the skin or into the muscles.

Epinephrine Auto-Injector Market Dynamic

Drivers

  • Rise in allergies

As the prevalence of allergies rises related to food additives, dust and latex, so demand of auto-injectors, propelling the global market for epinephrine auto-injector forward. 

  • Technological developments

The epinephrine auto-injector market's growth is fueled by factors including increased awareness of allergies, technological developments in research and development (R&D) activities, and chlorofluorocarbon-free auto-injector inhalers using hydrofluoroalkane propellants, and a high demand for auto-injectors rather than more conventional devices like standard epinephrine.

  • Increasing incidence of anaphylaxis

One of the main factors propelling the epinephrine market's rise is the rising prevalence of anaphylaxis. A major allergic reaction called anaphylaxis, which can be fatal, can happen minutes after being exposed to an allergen. Anaphylaxis affects roughly 1 in 50 persons in the UK annually, and this figure is rising, per an Allergy UK research. In the upcoming years, it is anticipated that the rising allergy rate would increase demand for epinephrine-based medicines.

Opportunities

Due to the rise in patients with allergies to dust, food, food additives, insect stings, and venom, the market has expanded. The fact that these auto-injectors are crucial for treating anaphylaxis and enable non-medical people to successfully treat the condition will probably lead to an increase in demand for epinephrine auto-injectors globally.

Restraints/Challenges

On the other hand, the regulatory barriers and expensive expenses will obstruct the market's growth rate.

This epinephrine auto-injector market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the epinephrine auto-injector market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Epinephrine Auto-Injector Market

The COVID-19 had an impact on the world economy by directly altering supply and demand, disrupting the supply chain and the market, and having an economic impact on businesses and financial markets. Most nations have lifted their lockdown laws, but because people are worried about the coronavirus, they avoid going to the doctor in person (COVID-19). As a result, businesses in the epinephrine auto-injector market are using telemedicine since people in the COVID-19 era demand remote healthcare services. Over the course of the forecast period, telehealth technology demand is anticipated to soar significantly.

Global Epinephrine Auto-Injector Market Scope

The epinephrine auto-injector market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  •  0.30 mg
  •  0.15 mg

Application

  •  Under 6 Years
  •  6 to 12 Years
  •  Over 12 Years

End-User

Epinephrine Auto-Injector Market Regional Analysis/Insights

The epinephrine auto-injector market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.

The countries covered in the epinephrine auto-injector market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the epinephrine auto-injector market due to the growing number of geriatric population along with adoption of innovative medical technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Epinephrine Auto-Injector Market Share Analysis

The epinephrine auto-injector market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to epinephrine auto-injector market.

Some of the major players operating in the epinephrine auto-injector market are:

  • Adamis Pharmaceuticals Corporation (U.S.)
  • ALK (Denmark)
  • Antares Pharma (U.S.)
  • Bausch + Lomb Incorporated (U.K.)
  • Hospira, Inc. (U.S.)
  • Impax Laboratories, Inc. (U.S.)
  • Lincoln Medical (U.S.)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Impax (U.S.)
  • Pfizer Inc. (U.S.)
  • Amphastar Pharmaceuticals, Inc. (U.S.)
  • Emerade (U.S.)
  • Grand Pharma Group Limited (Hong Kong)
  • Harvest Pharmaceuticals (U.S.)
  • Merit Healthcare International Inc. (U.S.)
  • Tianjin Jinyao Group (China)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Testimonial
Claudio Rondena Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future